Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 5e. TASK NUMBER 5f. WORK UNIT NUMBER
REPORT DATE
01-02-2006
REPORT TYPE
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBERNorthern California Institute for Research and Education San Francisco, CA 94121
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)
U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTESOriginal contains colored plates: ALL DTIC reproductions will be in black and white.
ABSTRACTThe TSPY gene is the only functional gene within the critical region harboring the gonadoblastoma locus on the Y chromosome (GBY). Expression studies demonstrated that it is aberrantly expressed in prostate cancer. This project is designed to address the role of this putative oncogene on the Y chromosome in this male-specific cancer. The objectives are: 1) to identify the oncogenic or tumor promoting domain in TSPY, and 2)to correlate TSPY over-expression with prostatic oncogenesis in transgenic mice. For the past year, we have examined the TSPY expression in additional 61 cases of prostate cancer and demonstrated that its expression is proportional to the degrees of malignancy of these clinical samples. Similar study of a tissue recombination model of prostate cancer demonstrated the same results, suggesting TSPY expression is intimately associated with prostate cancer. Significantly, studies of a line of transgenic mice harboring 50 copies of the human TSPY gene on their Y chromosome demonstrated that TSPYis expressed in hyperplasic regions of the prostates of old mice, resembling those of latent cancer in old men. These findings are significant, supporting the role of TSPY in the initiation of prostatic oncogenesis. For the next 12-month period, we plan to continue our characterization of our transgenic mice to confirm TSPY as an oncogene.
SUBJECT TERMS
INTRODUCTIONThe TSPY gene is a tandemly repeated gene on he short arm of the human Y chromosome. Genetic mapping and complet...